Please enter valid quantity
Please log in to add favorites.
NULL OR EMPTY CART
Our ViewPlate microplates are engineered for bottom reading systems and high content imaging.
Extracellular matrix proteins such as collagen provide an attachment framework for the adhesion and growth of certain cell types in vivo, and can also be used for cell attachment to plate surfaces in vitro. Cellular fibronectin membrane proteins mediate the attachment of cells to collagen substrates. Collagen is the most abundant protein in mammals that is found throughout the body and is a major component of the extracellular matrix (ECM). The most frequently used types of collagen for coating are collagen I and IV. Collagen type I is suitable for endothelial and epithelial cells, muscle cells and hepatocytes. Collagen type IV is the major constituent of basement membranes and offers more physiologically relevant conditions to cells as well as improving the adherence of specific cell types i.e. PC-12 (rat adrenal pheochromocytoma cell line). Our catalog plates are coated with rat tail collagen Type I.
Leveraging years of assay and instrument experience in plate detection, PerkinElmer designs better microplates for better performance that guarantees better results for all PerkinElmer applications.
Well format: 96-well
|Number of Rows||8|
|Number of Columns||12|
|Well volume||360 µL|
|Recommended working volume||80 µL- 350 µL|
|Well diameter (mm)||6.1|
|Well depth (mm)||11.4|
|A1 to top offset (mm)||11.3|
|A1 to side offset (mm)||14.3|
|Well-to-well spacing (mm)||9|
|Detection Method||Luminescence, Fluorescence|
|Product Brand Name||ViewPlate|
|Unit Size||Case of 160|
|Wells Number||96 well plate|
Find out about our range of integrated solutions for drug discovery screening in this e-brochure.
Our screening solutions for high-throughput screening, phenotypic screening and data analysis help to streamline drug discovery workflows in labs across the globe. Our portfolio includes automated liquid handling, assays and reagents, imaging and detection systems, and informatics.
Working independently or together, with our solutions you can achieve consistent and accurate results. By accelerating the identification and characterization of effective and safe drug candidates, the PerkinElmer portfolio enables you to optimize efficiency in your lab and deliver more actionable, real-world results.
Download the brochure to learn more about how we can partner with you so that you can discover smarter, more effective, data-driven breakthroughs in the critical screening stages of drug discovery and development.